News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bioenvision (BIOV) And Mayne Pharma USA Inc. Announce Marketing And Distribution Agreement For Evoltra(R)


5/16/2006 1:44:44 PM

NEW YORK--(BUSINESS WIRE)--May 16, 2006--Bioenvision, Inc (NASDAQ: BIVN - News) and Mayne Pharma Limited (ASX- MYP) today jointly announced that they have entered into a Marketing and Distribution Agreement for the innovative new cancer product, Evoltra® (clofarabine).

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES